Competing interests
P.N.T. has received personal compensation for consulting, serving on scientific advisory boards, and other activities from AbbVie, AC Immune, Acadia, Auspex, Boehringer Ingelheim, Chase Pharmaceuticals, Corium, Eisai, GliaCure, INSYS Therapeutics, Pfizer, T3D, AstraZeneca, Avanir, Biogen, Eli Lilly, H. Lundbeck A/S, Merck and Company and Roche; holds a provisional patent on ‘Biomarkers of Alzheimer’s Disease’ at the University of Rochester; holds stock options in Adamas; received research support from AstraZeneca, Avanir, Biogen, Eli Lilly, H. Lundbeck A/S, Merck and Company, Roche, Amgen, Avid, Functional Neuromodulation, GE Healthcare, Genentech, Novartis, Takeda, Targacept, the National Institute on Aging and the Arizona Department of Health Services. H.Z. has served on scientific advisory boards for Roche…
